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ABSTRACT  Analysis  of viral  glycoprotein  expression  on  surfaces  of  monensin-treated  cells 
using  a fluorescence-activated  cell  sorter (FACS) demonstrated  that  the  sodium  ionophore 
completely  inhibited  the  appearance  of  the  vesicular  stomatitis  virus  (VSV) G  protein  on 
(Madin-Darby canine kidney) MDCK cell surfaces.  In contrast, the expression of the influenza 
virus hemagglutinin  (HA) glycoprotein on the surfaces of MDCK cells was observed to occur 
at high levels,  and the time course of its appearance was not altered by the ionophore. Viral 
protein  synthesis  was not  inhibited  by  monensin  in  either VSV-  or  influenza virus-infected 
cells.  However, the electrophoretic mobilities of viral glycoproteins were altered, and analysis 
of pronase-derived  glycopeptides  by gel  filtration  indicated  that  the  addition  of sialic  acid 
residues  to the VSV G protein was impaired in monensin-treated cells. Reduced incorporation 
of fucose and galactose  into influenza virus HA was observed in the presence of the ionophore, 
but the incompletely processed  HA protein was cleaved,  transported to the cell surface,  and 
incorporated  into  budding virus  particles.  In contrast to the differential  effects  of monensin 
on VSV and  influenza virus replication  previously observed  in  monolayer cultures of MDCK 
cells,  yields of both viruses  were found to be significantly  reduced by high concentrations of 
monensin  in  suspension  cultures,  indicating  that  cellular  architecture  may  play  a  role  in 
determining  the  sensitivity  of  virus  replication  to  the  drug.  Nigericin,  an  ionophore  that 
facilitates  transport  of  potassium  ions  across  membranes,  blocked  the  replication  of  both 
influenza  virus  and  VSV  in  MDCK  cell  monolayers,  indicating  that  the  ion  specificity  of 
ionophores influences their effect on the replication of enveloped viruses. 
Cells infected with enveloped RNA viruses provide valuable 
systems for elucidating the pathways involved in subcellular 
transport of membrane glycoproteins (8, 20, 44).  As a result 
of viral inhibition of host protein synthesis, only one or a few 
viral membrane glycoproteins are synthesized in infected cells. 
These viruses possess limited genetic capacity, and the glyco- 
sylation and transport of their membrane glycoproteins to the 
cell surface are probably carried out by the same systems used 
by the host cell for biogenesis of its own membrane glycopro- 
teins. 
Monovalent ionophores such  as  monensin,  which  is  re- 
ported to interfere with the translocation of secretory as well 
as most membrane glycoproteins, have been used to charac- 
terize the pathways of intracellular glycoprotein transport in 
eucaryotic cells (18,  37-41,  43).  In addition,  the effects of 
monensin on IgM and  H2 glycosylation in  lymphoid cells 
and fibronectin glycosylation in cultured human fibroblasts, 
as well as its influence on oligosaccharide maturation of viral 
glycoproteins have also been reported (14,  19,  24,  38,  39). 
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These effects are thought to be a consequence of inhibition of 
glycoprotein transport by the ionophore.  We have recently 
provided evidence that, in polarized epithelial cells,  systems 
for transport of glycoproteins of two enveloped viruses to the 
cell surface differ in their sensitivity to monensin (1). These 
results were obtained with enveloped viruses that insert their 
membrane glycoproteins  into  different  plasma  membrane 
domains in Madin-Darby canine kidney (MDCK) 1 cell mon- 
olayers:  vesicular  stomatitis  virus  (VSV),  which  forms  at 
basolateral membranes, and influenza virus, which is assem- 
bled at the  free apical surface (27).  Replication  of VSV in 
MDCK cells was inhibited  markedly by monensin,  with  a 
block occurring in the transport of the G  protein to the cell 
Abbreviations used in this paper: FACS, fluorescence-activated  cell 
sorter; HA,  hemagglutinin; MDCK,  Madin-Darby canine  kidney; 
m.o.i., multiplicity of  infection; PBS, phosphate-buffered saline; PBS- 
BSA, PBS def containing 1% BSA; PBS def, PBS deficient in calcium 
and magnesium; VSV, vesicular stomatitis virus. 
659 surface.  In contrast,  influenza virus  maturation was not af- 
fected  significantly,  even at high concentrations of the iono- 
phore. 
To further analyze the effects  of monensin on replication 
of these enveloped viruses,  we investigated  the effects  of the 
ionophore on viral protein synthesis and the glycosylation of 
viral  membrane glycoproteins.  In addition,  we  studied the 
transport of viral membrane glycoproteins to the cell surface 
and the maturation of virions under conditions of monensin 
inhibition. We also compared the effect of monensin on virus 
assembly in  monolayers vs.  suspension cultures  of MDCK 
cells, and determined the effect on virus replication  of another 
ionophore that differs from monensin in ion specificity. 
MATERIALS  AND  METHODS 
Cells and Viruses:  MDCK and Madin-Darby bovine kidney (MDBK) 
cells were grown by described  procedures  (32). BHK21 cells were grown as 
previously described 03). All cells were grown at 37"C in an atmosphere of 5% 
CO2 in air. Stocks of influenza virus, A/WSN(H~N~)  strain, were prepared in 
MDBK cells (7), and stocks of the Indiana strain of VSV were propagated in 
BHK21 cells (32). Infectivity titers of influenza virus were assayed by plaquing 
on MDCK cells (42) and of VSV by plaque assay on BHK21 cells (32). 
Antibody Production:  Two monoclonal  antibodies prepared in our 
laboratory were used throughout this study: CB3-4, specific for the hemagglu- 
tinin (HA) protein  of A/WSN influenza virus and DC3-22, specific for the G 
protein of the Indiana strain of VSV. The antigen used for immunization was 
prepared as follows:  confluent cultures of MDCK cells were infected with either 
influenza  virus  or VSV, harvested  at  8  h  postinfection,  and  processed for 
membrane fractionation  by described procedures (5). The fraction containing 
smooth membrane vesicles was mixed with complete  Freund's adjuvant  and 
used as antigen for the initial immunization of mice; in subsequent  immuni- 
zations, smooth membrane vesicles  in PBS were used in the absence of  adjuvant. 
The immunization schedule and  cell fusion  procedure  were carded  out as 
described by Kearney et al. (15, 16). Enzyme-linked immunoadsorbent assay 
(ELISA) with smooth membrane fractions from either influenza virus- or VSV- 
infected MDCK cells as antigen was used for screening positive hybrids, and 
were then  recloned  by  procedures  detailed  elsewhere  05,  16). Additional 
screening of recloned  hybrids,  e.g. indirect  immunofluorescence  as well as 
immunoprecipitation  of polypeptides from virus-infected cells, was done to 
determine  the specificity of the clones. The monoclonal  antibodies were also 
found to show positive reaction with G or HA proteins from monensin-treated 
virus-infected cells by indirect  immunofluorescence  or immunoprecipitation. 
Monoclonal  antibodies  were obtained  as ascites fluids of hybridoma-bearing 
mice. 
Immunofluorescence  and FACS Analysis:  Confluent  MDCK 
cell monolayers in 60-mm plastic petfi dishes were washed twice with PBS and 
infected with either influenza virus at a multiplicity of infection (m.o.i.) of 1.0 
or VSV (m.o.i.  =  2.0). After a 2-h adsorption  period,  unadsorbed  virus was 
aspirated and replaced with serum-free Dulbecco's medium with or without a 
l0  -5  M  final  concentration  of monensin. At intervals  postinfection,  virus- 
infected cells were washed twice with PBS deficient in calcium and magnesium 
(PBS d.ef). A  30  mM  solution  of EGTA  in  calcium-free  Eagle's minimal 
essential medium was then added  and cells were incubated  at 37°C from 30 
rain to l h. In the case of monensin-treated  cells, the 30 mM EGTA solution 
also contained  a  final  l0  -5 M concentration  of the ionophore.  Rounded-up 
cells were transferred to conical centrifuge tubes and washed once with PBS 
def. Cells were fixed with  1%  formaldehyde, washed twice, and reacted with 
0.1  M lysine in PBS def. After washing, cells were resuspended in  100 #l of 
antiserum  diluted  with PBS def containing  I% BSA (PBS-BSA). Incubation 
with antiviral antibody was carried out for 20 rain at room temperature.  Cells 
were washed twice with PBS-BSA and resuspended in  100 #1 of fluorescein- 
conjugated anti-mouse  immunoglobulin.  After a 20-rain  incubation  at room 
temperature, cells were washed twice, fixed with 1% formaldehyde, and reacted 
with 0. l M lysine. A suspension of ~2 x  l06 cells/ml was filtered through glass 
wool to obtain a single cell suspension before analysis in a FACS IV fluores- 
cence-activated cell sorter. 
Radiolabeling  of Virus-infected  Cells:  Confluent  MDCK  or 
BHK21 cell monolayers in 35-mm or 60-ram dishes were washed twice with 
PBS and  infected  with  either  influenza  virus  or VSV  (m.o.i.  =  20). After 
adsorption at 37"C for 2 h, monensin  was added to a final l0  -~ M concentration. 
At times indicated  in the text, cells were labeled with L-[4,5-3H]leucine (59.2 
Ci/mmol), D-[6-~H]glucosamine (20.2 Ci/mmol),  D-[2-3H]mannose (18  Ci/ 
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mmol), L-[6-aH]fucose  (84 Ci/mmol),  o-[1-3H]galactose (8.2 Ci/mmol),  or O- 
[ I-~4C]glucosamine (57.9 mCi/mmol). At the end of the labeling period, cells 
were lysed in sample reducing buffer (0.0625 M Tris-HCl, pH 6.8 containing 
0.5% 2-mercaptoethanol,  10% glycerol, and 2.3% SDS). 
Polyacrylamide Gel Electrophoresis:  Samplesforgelelectropho- 
resis were boiled for 2 min before loading. Either 7.5% or 10% polyacrylamide 
slab gels 07) were run for 16-18 h at an 8 mA-constant  current  per slab gel. 
Gels were fixed in 10% acetic acid-40% methanol in distilled water for 30 min, 
and prepared for fluorography (2). Gels were dried under vacuum and exposed 
on Kodak X-Omat AR films at -70°C. 
Isolation of Viral Clycoproteins:  [3H]Glucosamine-labeled or [aH]- 
mannose-labeled purified virions or virus-infected cell lysates were loaded on 
preparative  10%  polyacrylamide  slab gels with a single well that covered the 
width of the gel. At the end of the run, a  l-cm wide strip obtained by cutting 
the slab gel longitudinally at the center was sliced manually into l-mm slices. 
Gel  slices were soaked overnight  at  37"C in 0.3  ml of 90%  Protosol  (New 
England Nuclear, Boston, MA); 4.0 ml of a toluene-Liquifluor  (New England 
Nuclear) scintillation cocktail mixture was then added. Gel slices were counted 
in a Scarle liquid scintillation counter,  and the location of glycoprotein peaks 
was determined.  The glycoproteins were eluted  electrophoretically  from the 
remaining gel using an ISCO protein concentrator  (ISCO, Inc., Lincoln, NE). 
The glycoprotein  samples were either  lyophilized overnight  or immediately 
digested with glycosidases. 
Pronase Digestion  and  Gel  filtration  of Viral Glycopep- 
tides:  Glycoprotein samples were incubated with pronase for 72 h at 60"C 
(10). Viral  glycopeptides were then chromatographed  on a  Bio-Gel P6  gel 
filtration column (200--400 mesh,  1.0 cm x  ll5 cm) with a flow rate of 3.2 
ml/h  at  4"C. The  columns were  calibrated  using  [~4C]glucosamine-labeled 
Sindbis virus glycopeptides as molecular weight markers,  l-ml fractions were 
collected and 0.3-ml aliquots, to which 8.0 ml of Scintiverse (Fisher Scientific 
Co., Pittsburgh, PA) scintillation cocktail was added, were counted. Glycopep- 
tide peaks of interest were pooled,  lyophilized, and desalted  on Bio-Gel P2 
columns (50-100 mesh, 1.5 cmx 25 cm). 
Neuraminidase Digestion:  Desalted glycopeptide samples were dis- 
solved in 0.5 ml of 0.1 M sodium acetate buffer (pH 5.5), digested with 100 #i 
of neuraminidase  (500 U/ml) for 24 h at 37"C (22), and analyzed on Bio-Gel 
P6 columns. 
Endo-15-N-acetylglucosaminidase-H  (endo-H)  Digestion: 
After desalting, glycopeptide fractions were pooled, lyophilized, and dissolved 
in 100 ~tl of 0.05 M citrate-phosphate buffer (pH 6.5) and digested with 0.02 U 
ofendo-H for 24 h at 37"C (22), before chromatography on Bio-Gel P6 columns. 
Chemicals and Isotopes:  Monensin,  nigericin, pronas¢, and neur- 
aminidase were purchased from Calbiochem-Behring Corp, La Jolla, CA. Endo- 
H was obtained  from Miles Laboratories, Inc, Elkhart,  IN. [3HlLeucine (59.2 
Ci/mmol), [3H]glucosamine (20.2 Ci/mmol) and [3H]fucose  (84 Ci/mmol) were 
purchased from New England Nuclear, Boston, MA, and [3H]mannosc (I 8 Ci/ 
retool), [3H]galactose (8.2 Ci/mmol), and [~4C]glucosamine (57.9 mCi/mmol) 
were obtained from Amersham Corp., Arlington Heights, IL. 
RESULTS 
Quantitative Analysis of Glycoprotein Expression 
on Surfaces of Virus-infected MDCK Cells Treated 
with Monensin 
The  expression  of influenza  virus  HA  glycoprotein and 
VSV G  protein on surfaces  of control or monensin-treated 
MDCK cell  monolayers was quantitated with a FACS. The 
FACS plots of VSV-infected MDCK cells in the presence or 
absence  of  10  -5  M  monensin  (Fig.  1A-D) show  that  the 
expression  of G  protein  on  surfaces  of untreated  cells  in- 
creased  progressively  during  the course of infection. In con- 
trast,  monensin-treated cells showed no fluorescence above 
background levels even at l0 h postinfection. Thus, monensin 
completely inhibited the transport of G protein to the surfaces 
of MDCK cells.  On  the  other hand,  the  FACS profiles  of 
MDCK cells  infected  with influenza virus (Fig.  l E-H) re- 
vealed increasing  levels of HA  on cell  surfaces  as infection 
progressed, in the presence or absence of the ionophore. The 
time course of appearance of influenza virus HA protein from 
6-10 h postinfection was apparently  unaltered  by the iono- ~,q  B 
A 
z 
-  c  .._1 
ILl  ,,~'  ~ 
E 
/L£ 
G 
Log FLUORESCENT  INTENSITY 
r 
FIGURE  1  Effect  of  monensin  on  cell  surface  expression of viral 
membrane  glycoproteins.  (A-D)  FACS profiles  of  VSV-infected 
MDCK cells (m.o.i. =  2.0) in the presence (- -  -) or absence (  ) 
of  10  -s  M  monensin.  Cells  were  harvested  at  6,  8,  and  10  h 
postinfection  and  processed  for  indirect  surface  fluorescence  as 
described in Materials and Methods. (A)  Background fluorescence 
of  uninfected  MDCK  cells  (  )  and  VSV-infected  cells  at  8  h 
postinfection in which addition of the first antibody was omitted 
(- -  -).  (B-D) VSV-infected  cells at 6  h  (B), 8  h  (C), and  10  h  (D) 
postinfection; control (  ); monensin-treated (- -  -). (E-H) FACS 
profiles of influenza virus-infected  MDCK  cells (m.o.i. =  1.0) at 6, 
8, and 10 h postinfection in the presence (- -  -) or absence (  ) 
of  10  -s  M  monensin.  (E)  Background  fluorescence  of  uninfected 
MDCK cells (  ) and influenza virus-infected cells at 8  h  postin- 
fection in which addition of the first antibody was omitted (- -  -). 
(F-H) Influenza virus-infected cells at 6 h (F), 8  h (G), and 10 h  (H) 
postinfection; control (  ); monensin-treated (- -  -). 
proteins in monolayers of MDCK or BHK21 cells. In contrast 
to MDCK, BHK21  cells are fibroblastic and do not exhibit 
polarity  of virus  maturation;  i.e.  influenza  virus  or  VSV 
assemble over most of the cell surface. As shown in Fig.  2, 
there was a  slight increase in the electrophoretic mobility of 
G  protein in VSV-infected MDCK cells treated with  10  -6 M 
monensin; this shift was more pronounced in BHK21 lysates. 
No alteration was detected in any of the nonglycosylated viral 
proteins. In parallel experiments, a decrease in the molecular 
weight of influenza virus HA was also detected in monensin- 
treated BHK21 cell lysates. In influenza virus-infected MDCK 
cells,  the  control  protein  pattern  showed two bands corre- 
sponding  to  HA,  which  we  have designated  as  upper and 
lower HA bands. In monensin-treated MDCK cells, only the 
lower HA  band  was detected  and  it  appeared to  be  more 
intense than  the  lower HA band of controls.  These results 
suggest that changes in the glycosylation of viral glycoproteins 
occur in monensin-treated cells. As observed with VSV, syn- 
thesis of the  nonglycosylated viral proteins appeared to be 
unaffected by the ionophore. 
Pulse-chase analysis of  influenza virus-infected MDCK cells 
in the presence or absence of l0  -6 M  monensin was used to 
further investigate the two forms of influenza virus HA gly- 
coprotein  shown  in  Fig.  2.  After a  10-min  pulse,  only the 
lower HA band was detected (Fig. 3). Some of the lower form 
appeared to be converted into the Upper HA band in a  30- 
min  chase;  after a  60-min  chase  period,  most  of the  HA 
phore, since the fluorescence intensity profiles of control and 
monensin-treated cells were virtually indistinguishable at each 
time point examined. 
Even after short intervals following virus labeling, e.g., 20- 
60 min, influenza virus HA protein was already detected on 
the surface of monensin-treated MDCK cells. Influenza virus- 
infected cells were pulsed with [3H]mannose and chased with 
20  mM  cold  mannose  in  the  presence  or  absence  of the 
ionophore, and  cell surface glycoproteins were analyzed by 
exposure  of intact  cells  to  anti-HA  monoclonal  antibody, 
followed by lysis  and  immune precipitation.  No significant 
differences were found in the kinetics of appearance of HA 
on surfaces of control vs. monensin-treated cells (not shown). 
Viral Protein  Synthesis  in Monensin-Treated  Cells 
To further analyze the  effects of monensin  on  influenza 
virus and VSV replication, we examined the synthesis of viral 
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FIGURE  2  Synthesis of viral proteins in  MDCK  or BHK21  cells in 
the  presence  or  absence  of  10  -6  M  monensin.  Control  (-)  or 
monensin-treated (+) cells were infected with either influenza virus 
(WSN  strain) or VSV at an m.o.i, of 20.  Infected MDCK cells were 
pulse-labeled for 1 h with [3H]leucine at 7 h postinfection for WSN 
or at 9  h  postinfection for VSV.  BHK21  cells were labeled for  1 h 
with [3H]leucine at 8 h postinfection for WSN or at 6 h postinfection 
for VSV. Cells were then lysed in sample reducing buffer described 
in  Materials and  Methods and  analyzed on  7.5%  polyacrylamide 
gels.  N.B.  Influenza  M  protein,  present  in  both  untreated  and 
monensin-treated BHK21  cell lysates, had run off together with the 
dye marker in this gel. 
Viral  Glycoprotein  Glycosylation  and Transport  661 FIGURE  3  SDS PAGE analysis of processing of influenza virus  HA 
in MDCK cells.  Cells were pulsed for 10 rain at 8  h postinfection 
(10'p) with [3H]leucine in leucine-deficient Eagle's minimal essen- 
tial medium in the presence or absence of 10  -6 M monensin. Media 
containing 10-fold excess leucine with or without monensin was 
then  added for  a  30-min  (30'c)  or  60-min  (60'c)  chase  period. 
Roughly  100,000  cpm of each cell lysate was analyzed on  7.5% 
polyacrylamide gels. 
molecules were found in the upper band. These results suggest 
that  the  upper  HA  band  is  the  mature  form  derived by 
processing of the lower HA band. In the presence of 10  -6 M 
monensin, the lower band was not chased into the upper HA 
band even after 60 min. 
Glycosylation  of VSV G in MDCK and 
BHK21 Cells 
The faster electrophoretic mobility of vgv O  protein in 
monensin-treated cells  suggested  possible  alterations  in  its 
oligosaccharide processing.  To further investigate this  phe- 
nomenon,  we  analyzed the  oligosaccharides of G  protein 
isolated from VSV-infected MDCK or BHK21 cells radiola- 
beled with [3H]- or ['4C]glucosamine sugar precursors for 4 h 
in the presence or absence of 10  -5 M monensin. Chromatog- 
raphy of  glycopeptides obtained after extensive pronase diges- 
tion of G protein from untreated VSV-infected MDCK cells 
(Fig. 4A) revealed a major glycopeptide size class of ~2,800- 
4,200 mol wt (fractions 45-53) with several shoulders of  lower 
mol wt components that probably differ in sialic acid content, 
as reported by other investigators (4, 9). In the case of G from 
monensin-treated cells,  two  major glycopeptide size  classes 
were resolved with molecular weights of 2,400-4,000 (frac- 
tions 46-55) and 1,600-2,200 (fractions 57-63), respectively. 
Glycopeptides in G protein from control or monensin-treated 
cells  were found to be predominantly resistant to endo-H, 
indicating that they contain complex sugars (data not shown). 
The larger glycopeptide size classes were sensitive to digestion 
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FIGURE  4  Glycopeptides of VSV 
G protein from untreated or mo- 
nensin-treated MDCK  or BHK21 
cells.  Cells  were  infected  with 
VSV at an m.o.i, of 20 and labeled 
for  4  h  at  6  h  postinfection 
(MDCK)  or  at  4  h  postinfection 
(BHK21)  with  either  [14C]gluco- 
samine (control, O) or [3H]gluco- 
samine (+  10  -5 M  monensin, O). 
VSV G protein was isolated as de- 
scribed in Materials and Methods. 
The  control  and  monensin- 
treated glycoproteins were co-di- 
gested with pronase and analyzed 
by  gel  filtration  on  Bio-Gel  P6. 
One-third  of  the  volume  from 
each fraction was used for radio- 
activity determination,  and the re- 
mainder was pooled, lyophilized, 
and  desalted  before  digestion 
with  neuraminidase.  The  neur- 
aminidase-treated  G  glycopep- 
tides  were  rechromatographed 
on Bio-Gel P6 columns, and the 
entire fractions were counted. (A) 
Pronase digests from control and 
monensin-treated  MDCK  cells. 
(B) Neuraminidase digests of gly- 
copeptides from control and mo- 
nensin-treated  MDCK  cells.  (C) 
Pronase digests from control and 
monensin-treated BHK21 cells. (D) Neuraminidase digests of glycopeptides from control and monensin-treated BHK21 cells. 
662  THE  JOURNAL  OF  CELL  BIOLOGY  •  VOLUME  97,  1983 with  neuraminidase  (Fig.  4B),  resulting  in  lower  mol  wt 
species. However the smaller glycopeptides present in G pro- 
tein from monensin-treated cells were apparently not affected 
by neuraminidase, indicating that they do not contain sialic 
acid residues. Similar observations were made with G protein 
isolated  from  VSV-infected BHK  cells  (Fig.  4C-D). The 
control G glycoprotein contained a major glycopeptide peak 
(fractions 45-54) of ~2,600-4,200 tool wt (Fig. 4 C) while G 
protein from monensin-treated cells yielded two major size 
classes with apparent mol wts of 2,800-4,000 (fractions 46- 
53) and 1,600-2,300 (fractions 56-63). The larger glycopep- 
tides  contained  sialic  acid  residues  as  evidenced by  their 
sensitivity  to  digestion  with  neuraminidase,  whereas  the 
smaller glycopeptides in G from monensin-treated cells were 
again found to be neuraminidase-resistant (Fig. 4D). These 
results indicate that monensin impairs the addition of sialic 
acid to a  significant fraction of oligosaccharides on the G 
glycoprotein in infected MDCK or BHK21 cells. 
Glycosylation  of Influenza  Virus HA in MDCK 
and BHK21 Cells 
The absence of the upper HA band in monensin-treated 
MDCK cells and the faster electrophoretic mobility of HA 
protein in BHK21 cells exposed to monensin suggested alter- 
ations in glycosylation  of  HA in the presence of  the ionophore. 
To investigate this possibility, we analyzed the glycopeptides 
obtained by pronase digestion of HA glycoproteins. It has 
been  previously reported that  influenza HA  contains  two 
types of oligosaccharide chains: type I (complex) oligosaccha- 
rides contain glucosamine, galactose, mannose, and fucose, 
whereas type II oligosaccharides consist of a high amount of 
mannose in addition to glucosamine, but lack galactose and 
fucose (23).  Type II glycopeptides have been resolved into 
two size classes, designated IIa and IIb. In the upper HA band 
from  untreated  influenza virus-infected MDCK  cells  (Fig. 
5A),  we observed a  major glycopeptide size  class  with  an 
apparent mol wt of -~2,800-3,500 corresponding to type I 
glycopeptides (fractions 48-53), two additional peaks in the 
type II region with mol wts of 2,100-2,200 (fractions 55-58) 
and  1,500-1,900  (fractions 60-64)  and  a  shoulder in  the 
1,300-1,500 region (fractions 66-68).  The lower HA band 
from  monensin-treated  cells  contained  glycopeptides  of 
~2,100-3,000  daltons  (fractions  51-58)  and  shoulders  of 
glycopeptides with mol wts of "~ 1,700-2,000 (fractions 59- 
62) and 1,300-1,600 (fractions 63-66). Endo-H treatment of 
HA glycopeptides from control or monensin-treated cells (Fig. 
5 B) indicated that the larger glycopeptide size classes were of 
the complex type while the smaller glycopeptides were man- 
nose-rich.  The  minor peak  in  fractions 68-75  in  Fig.  5B 
presumably  represents  mannose-rich  side  chains  that  are 
cleaved from  the  glycopeptides by endo-H digestion.  The 
molecular weights  of the cleavage products from untreated 
cells were found to be slightly larger than those of HA from 
monensin-treated cells. 
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FIGURE  5  Glycopeptides  of influenza virus HA from untreated or monensin-treated  MDCK or BHK21 cells. Cells were infected 
with influenza virus  (m.o.i. =  20) and labeled for 4  h at 4  h  postinfection (MDCK and BHK21)  with either [14C]glucosamine 
(control, O) or [3H]glucosamine (+10  -5 M monensin, 0). Influenza virus HA glycoproteins isolated from untreated and monensin- 
treated cells were co-digested with pronase and analyzed as described in the legend to Fig. 4. Aliquots were digested with endo- 
H and rechromatographed on Bio-Gel P6 (A) Pronase digest of upper HA from untreated and lower HA, from monensin-treated 
/vIDCK cells.  (B) Endo-H digests of upper HA (control) and lower HA (monensin-treated) glycopeptides. (C) Pronase digests of 
lower HA from control and  monensin-treated MDCK  cells.  (D)  Endo-H  digests of lower HA glycopeptides  from control and 
monensin-treated MIgCK cells. (E) Pronase digests of HA from control and monensin-treated BHK21 cells. (F) Endo-H  digests of 
HA glycopeptides  from control and monensin-treated BHK21 cells. 
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band isolated from untreated MDCK monolayers (Fig.  5 C) 
revealed type I glycopeptides of 2,200-3,500 mol wt (fractions 
48-57) and type II glycopeptides with mol wt of 1,400-1,900 
(fractions 60-65). A major peak with an apparent mol vet of 
2,100-3,300  (fractions  49-58)  and  a  shoulder  of roughly 
1,400-1,900 (fractions 60-66) was observed in the lower HA 
band from monensin-treated cells. The smaller glycopeptides 
were endo-H sensitive, i.e.  mannose-rich, as shown in  Fig. 
5D,  while  the  major  glycopeptide  size  class  was  endo-H 
resistant. These data, in conjunction with the results of the 
pulse-chase experiments, suggest that the lower HA band is 
an incompletely processed form of the upper HA band. 
Glycopeptides with mol wt of 2,200-3,500  (fractions 48- 
57) and 1,500-2,000 (fractions 59-64) were resolved from the 
HA glycoprotein isolated  from  untreated  BHK21  cells in- 
fected with  influenza  virus (Fig.  5 E).  Gel filtration  of HA 
glycopeptides from monensin-treated  cells revealed a  peak 
with mol wt of 2,100-2,300 (fractions 51-58) and a shoulder 
of 1,300-1,900  (fractions 60-66).  Endo-H digestion of these 
glycopeptides (Fig.  5 F) indicated that only the smaller glyco- 
peptides contained mannose-rich oligosaccharides. 
These results indicate that in  monensin-treated cells,  HA 
glycoproteins contain  truncated  oligosaccharide chains that 
remain endo-H resistant. To investigate the changes in oligo- 
saccharide composition, we pulse-labeled influenza virus-in- 
fected  MDCK  cells  with  various  sugar  precursors  in  the 
presence or absence of l0  -~ M monensin. The results (Fig. 6) 
show  that  the  addition  of the  terminal  sugars  fucose  and 
galactose was significantly impaired in  the presence of mo- 
nensin.  Densitometer scans of the fluorograph (not shown) 
indicated  about  a  twofold  inhibition  in  incorporation  of 
[3H]fucose into HA, and more than a  10-fold inhibition in in- 
corporation of [3H]galactose.  In contrast, labeling with [3H]- 
glucosamine was not markedly inhibited in the presence of 
the  ionophore.  We  also  observed  that  incorporation  of 
[3H]mannose into  the  lower HA band either in  control  or 
monensin-treated cells was two- to fourfold higher than into 
the  upper HA band,  suggesting that trimming of mannose 
residues from mannose-rich oligosaccharides is  involved in 
conversion of the lower to the upper form. 
Assembly of Virions in Monensin-Treated MDCK 
Cells 
We investigated whether the lower HA band observed as 
the major species in monensin-treated MDCK cells was the 
form  of HA  that  was  transported  to  the  cell  surface  and 
subsequently incorporated into  budding virus particles. We 
purified influenza virions grown in MDCK cells in the pres- 
ence  of absence  of  10  -5  M  monensin.  Fig.  7  shows  that 
influenza virions obtained from monensin-treated cells con- 
tained the lower HA band; in contrast, virions from untreated 
cells  contained  the  upper  HA  band.  Cleavage of the  HA 
glycoprotein into  HA,  and  HA2  continued  to  occur in  the 
presence of the ionophore, and a shift in the electrophoretic 
mobility of HA,  was  observed in  virions  from monensin- 
treated cells;  no alteration in molecular weight was detected 
in HA2. The HA2 glycoprotein is known to contain only one 
oligosaccharide chain and therefore, a block in the addition 
of one  or two terminal  sugars by monensin would  not  be 
easily detected. Analysis of the glycopeptides indicated that 
virions from monensin-treated cells contained HA with in- 
completely processed complex oligosaccharides (Fig. 8A-B). 
664  THE  JOURNAL OF  CELL BIOLOGY • VOLUME 97,  1983 
FIGURE 6  Glycosylation of  influenza virus  HA  in  untreated  or 
monensin-treated MDCK cells. Influenza virus-infected cells (m.o.i. 
= 20) were pulse-labeled for 1 h at 7 h postinfection with 100/~Ci/ 
dish of various 3H-sugars, with or without 10  -s M monensin.  Equal 
volumes of cell lysates were analyzed on 10% polyacrylamide gels 
Lane A, [3H]leucine-labeled  influenza  virus-infected cell lysate used 
as marker;  lanes B (- monensin) and C (+monensin),  [3H]fucose- 
labeled; lanes D (-) and  E (+),  [3H]galactose-labeled;  lanes F (-) 
and  G  (+),  [3H]glucosamine-labeled;  and  lanes H  (-)  and  /  (+), 
[3H]mannose-labeled. 
FIGURE 7  Comparison of the envelope 
glycoproteins of influenza virions from 
control  and  monensin-treated  MDCK 
cells.  Influenza  virus-infected  cells 
(m.o.i.  =  10) were incubated in Eagle's 
minimal essential medium containing 10 
#Ci/ml  of  [3H]glucosamine,  with  or 
without 10  -s M monensin. Virus was har- 
vested after 24 h, purified and analyzed 
on a 7.5% polyacrylamide  gel; ~40,000 
cpm of each virus preparation  was used. 
Control, lane A; monensin-treated,  lane 
B.  The  HA2  protein migrated  together 
with the dye front in this gel. Two glycopeptide size classes of ~2,900  and  1,800 mol wt 
were  obtained  from  the  HA  protein  of virions  grown  in 
untreated  cells (Fig.  8A).  The lower mol wt HA protein  of 
virions from monensin-treated cells also contained the 1,800- 
dalton glycopeptides as well as a  major size class of ~-2,400 
daltons.  In  addition,  there  appears  to  be  a  lower  mol  wt 
shoulder  (fractions  61-65)  in  both  upper  and  lower  HA 
glycopeptides.  The  smaller  glycopeptides were  sensitive  to 
endo-H digestion (Fig. 8 B), indicating that they contain man- 
nose-rich oligosaccharides. These results demonstrate that HA 
molecules with  altered  complex oligosaccharides are  trans- 
ported  to  the  cell  surface  and  incorporated  into  influenza 
virions in monensin-treated cells. 
Although  VSV  virions  were  not  detected  at  surfaces  of 
monensin-treated  MDCK  cells by electron  microscopy (1), 
we investigated whether low levels of  virons could be obtained 
from  such  cells.  As  shown  in  Fig.  9,  virus  particles  were 
purified from monensin-treated cells and they contained all 
VSV structural proteins, but the amounts of  radiolabeled viral 
proteins  were greatly reduced.  These particles  contained  G 
protein with slightly faster electrophoretic mobility, similar to 
the incompletely glycosylated G  seen in infected cells treated 
with  the  ionophore.  Although  the  protein  content  of virus 
preparations  from monensin-treated  cells was only reduced 
by ~ 50%, a large amount of this represented contaminating 
cellular  material.  A  number  of cellular protein  bands  were 
evident in stained gels (not shown) or fluorographed protein 
gels of VSV particles  purified  from  monensin-treated  cells; 
the specific infectivity (plaque-forming units per ~g of  protein) 
of these  particles  was  only  3%  of the  control  value.  Since 
monensin  blocks  the  appearance  of G  protein  on  the  cell 
surface, and virus budding at cell surfaces was not observed, 
it is possible that some VSV virions may have been formed 
intracellularly in monensin-treated cells. 
Comparison  of the Effect of Monensin  on 
Replication  of Influenza Virus and VSV in 
Monolayer vs. Suspension Cultures of 
MDCK Cells 
We determined the effects of  monensin on virus yields from 
MDCK cells in a suspension culture system. As shown in Fig. 
10, yields of both influenza virus and VSV grown in suspen- 
sion  cultures  of MDCK  cells  were  significantly  reduced  at 
high concentrations of the  ionophore.  It was also observed 
that in the controls,  infectivity titers  of both viruses propa- 
gated  in  MDCK  suspension  cultures  were  ~  10-fold lower 
than virus yields obtained from MDCK monolayers. In par- 
allel  experiments,  yields  of infectious  VSV  obtained  from 
MDCK monolayers were significantly inhibited by monensin, 
whereas influenza virus replication was unaffected, as reported 
previously  (1).  These  results  indicate  a  significant  role  of 
cellular  architecture  in  determining  the  sensitivity  of enve- 
loped virus replication to monensin. 
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FIGURE  8  Analysis  of  HA 
glycopeptide profiles from 
purified  influenza  virions 
grown in untreated or mo- 
nensin-treated  cells.  Puri- 
fied  influenza  virus  parti- 
cles were prepared as de- 
scribed  in  the  legend  to 
Fig.  6.  However,  virions 
from  untreated cells were 
labeled with  [14C]glucosa- 
mine and virions from mo- 
nensin-treated  cells  were 
labeled  with  [3H]glucosa- 
mine.  HA  glycoproteins 
isolated  from influenza  vi- 
rus particles grown in con- 
trol  (@)  or  monensin- 
treated  (A) cells  were co- 
digested  with pronase and 
processed for gel filtration as described in the legend to Fig. 4  (A) 
Pronase digests of HA glycoproteins of influenza virions from con- 
trol or monensin-treated cells. (B) Endo-H digests of HA glycopep- 
tides of influenza virions from control or monensin-treated cells. 
FIGURE  9  Comparison  of 
protein  profiles  of  purified 
VSV virions from untreated or 
monensin-treated  MDCK 
cells. Cells were infected with 
VSV at an m.o.i, of 10. After a 
1 h adsorption period at 37"C, 
unadsorbed virus was aspira- 
ted  and  replaced  with  40*/. 
leucine-deficient  Eagle's min- 
imal  essential  medium  con- 
taining  5  /~C/ml of  [3H]leu- 
cine,  with  or without  10  -s M 
monensin.  Virus  was  har- 
vested  at  24  h  postinfection; 
an  aliquot  of the  culture  su- 
pematant was used for deter- 
mination of the infectivity titer 
and  the  remainder  was  puri- 
fied on a 5-40% linear potas- 
sium  tartrate  gradient.  About 
40,000  cpm  each  of  virions 
from  control (lane A) or mo- 
nensin-treated  cells  (lane  B) 
were analyzed on  10% poly- 
acrylamide gels. The structural 
proteins  of  [3H]leucine-la- 
beled  VSV  grown  in  BHK21 
cells  are  shown  as  standards 
(lane C). 
Effect of Nigericin  on Virus Yields 
Another  monovalent  ionophore,  nigericin,  has  been  re- 
ported to inhibit the secretion of procollagen and fibronectin 
from cultured human flbroblasts (43), as well as to preferen- 
tially block secretion of acetylcholinesterase in chick embryo 
skeletal  muscle cultures,  but not the appearance of the ace- 
tylcholine receptor,  an  integral  membrane  protein  (37).  In 
another report, however, it was found that nigericin disrupted 
ALONSO-CAPLEN AND  COMPANS 
the transport  of both the acetylcholine receptor and acetyl- 
cholinesterase  enzyme (35).  Nigericin  is selective  for potas- 
sium ions, whereas monensin facilitates sodium ion transport 
across membranes  (25).  We  observed that  treatment  of in- 
fected MDCK cells with concentrations of nigericin between 
10  -8 and  10  -6 M  reduced the yields of VSV by about twofold 
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FIGURE I0  Comparison of the effect of monensin on virus yields 
from MDCK monolayer and suspension cultures. Confluent MDCK 
cell monolayers were infected with  either influenza virus or VSV 
(m.o.i. =  10). MDCK suspension cultures were prepared by treating 
monolayers with 0.1% EDTA in PBS def for 30 rain at 37°C.  Cells 
were washed twice in PBS def and resuspended in Eagle's minimal 
essential  medium  modified  for  suspension  cultures.  Cells  were 
continuously rotated in a  "Labquake"  rotator at 37°C.  Monensin 
was added postadsorption to monolayers or after final pelleting to 
suspension  cultures.  After  24  h,  virus  yields  were  measured  by 
plaque  assays.  Influenza  virus  titers,  monolayers  (O);  VSV  titers, 
monolayers (A);  influenza  virus titers,  suspension  (0);  VSV  titers, 
suspension (A). At the  100% point, the influenza virus titers were 
3.9 x  107 plaque-forming unit (pfu)/ml (monolayer), 8.7 x  106 pfu/ 
ml (suspension), and the VSV titers were 1.3 x  10  a pfu/ml (mono- 
layer), 9.8 x  107 pfu/ml (suspension). Note that treatment of MDCK 
cells for up to 24 h with low concentrations of monensin, e.g., 10  -8 
to  10  -6  M  ,does  not  significantly  affect  cell  viability.  Prolonged 
treatment of cells with  I0  -s M  monensin results in a 60-70% cell 
viability, however, the  monensin-treated MDCK  cells remain as a 
monolayer with two well-defined surface domains. 
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FIGURE 11  Effect of nigericin on yields of infectious influenza virus 
and VSV  in MDCK  or  BHK21  cells.  Nigericin was added postad- 
sorption  to  either  MDCK  (A)  or  BHK21  (B)  cells  infected  with 
influenza virus or VSV (m.o.i. =  10). Culture fluids were harvested 
at  24  h  postinfection  and  infectivity  titers  were  determined  by 
plaque assays. Influenza virus titers (0); VSV titers (A). 
and the yields of influenza virus by two- to tenfold (Fig. l 1A). 
Both influenza virus and VSV replication in  MDCK cells 
were found to be significantly inhibited by 10  -5 M nigericin, 
in contrast to results obtained with monensin. The infectivity 
titers of  both viruses were also reduced in parallel experiments 
performed on BHK21 cells (Fig.  11 B). 
DISCUSSION 
We have used ionophores as probes to investigate the intra- 
cellular transport of viral glycoproteins. Our previous finding 
that VSV G protein transport to the cell surface is blocked by 
monensin, whereas influenza virus assembly and glycoprotein 
transport are not, suggested  that distinct pathways exist for 
transport  of glycoproteins  to  the  plasma  membranes  of 
MDCK cells (l). We also found that influenza virions assem- 
bled only at the apical surface of monensin-treated MDCK 
cells,  suggesting  that  HA  glycoprotein is  localized in  this 
membrane domain. The present results indicate that although 
the movement of influenza virus HA to the apical surfaces of 
MDCK monolayers is unaffected by monensin, glycosylation 
of HA is altered, i.e., the addition of fucose and galactose is 
impaired.  Evidence has  been  obtained that  the  inhibitory 
effects of monensin are at the point of exit of proteins from 
the Golgi complex en route to the plasma membrane (41, 43). 
Recently, it was reported that monensin inhibited the trans- 
port of Semliki Forest virus glycoproteins from the medial to 
trans Golgi cisternae (l 1). Sugar transferases involved in the 
addition of terminal sugars  to glycoproteins, e.g., galactosyl 
transferase,  are  located in  the  distal  compartments of the 
Golgi apparatus (30); the possibility that some sugar transfer- 
ases  are  inactive in  monensin-treated cells  seems  unlikely 
since VSV oligosaccharides appear to be complete except for 
the addition of sialic acid. Our data therefore strongly suggest 
that the pathway used for the transport of HA to the surfaces 
of monensin-treated cells bypasses at least some elements of 
the Golgi complex, thus accounting for the virtual absence of 
galactose.  The  incompletely glycosylated HA  proteins  are 
cleaved into HAl and HA2, and subsequently incorporated 
into budding influenza virions. The alterations in glycosyla- 
tion of  G protein by monensin are a consequence, rather than 
a cause of the block in its transport to the cell surface, since 
it was previously shown that complete inhibition of glycosy- 
lation by tunicamycin does not prevent VSV maturation (31). 
Our  results indicate  that  the  pathway  for transport  of G 
protein to  the  cell  surface  is  different from  that  used  by 
influenza virus HA protein, and is inhibited by monensin at 
the distal compartments of  the Golgl complex. Although sialyl 
transferases have been observed to be coisopycnic with gal- 
actosyl transferase, a marker enzyme of the distal Golgi com- 
plex (3),  it is possible that additional sialylation may occur 
after the glycoproteins exit from the Golgi apparatus, which 
would account for the partial inhibition of glycosylation of 
the G protein. 
Many cell lines of diverse epithelial origin, with morpho- 
logically well differentiated apical and basolateral surfaces and 
intercellular  junctions, exhibit properties of natural transport- 
ing epithelia in culture (l 2). When MDCK cells were grown 
on collagen-coated nylon nets, they developed a transepithe- 
lial electrical resistance, a transepithelial electrical potential, 
and a preferred selectivity for sodium over chloride ions (2 l). 
The presence of intact tight junctions correlated well with the 
ability to develop transepithelial electrical resistance and to 
form "domes" or hemicysts (6). Experiments involving infec- 
tion of dissociated MDCK cells with either influenza virus or 
VSV (28,  29) have indicated that attachment to a substrate 
or to adjacent cells is important for expression of epithelial 
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differential effects of monensin on the yields of viruses, we 
grew  influenza  virus  and  VSV  in  suspension  cultures  of 
MDCK  cells.  The  results  reveal  a  significant  influence  of 
cellular architecture in determining the resistance of influenza 
virus replication to monensin. It is possible that disruption of 
the normal transepithelial flow of  ions as a result of  suspension 
of MDCK cells may alter the sensitivity of enveloped viruses 
to monensin. In addition, a reduction in both virus yields was 
observed in  untreated  suspension  cells,  suggesting that  the 
interaction of the epithelial cells with a substratum is impor- 
tant for efficient virus replication. 
Reports that noninfectious VSV particles lacking viral gly- 
coprotein are produced by cells infected with ts 045 mutants 
of VSV at restrictive temperature (36) raise questions about 
the requirement for the viral glycoprotein in virus maturation 
at the cell surface. Our evidence indicates that G protein and 
all the other nonglycosylated proteins of VSV continue to be 
synthesized in the presence of monensin; however, transport 
of G  protein to the cell surface is effectively blocked by the 
ionophore, and the production of VSV particles in MDCK 
cells is significantly reduced. The G  protein probably accu- 
mulates in the Golgi apparatus as a result of the block in its 
transport to the cell surface. VSV particles released from drug- 
treated cells contained G protein with a slightly faster electro- 
phoretic mobility, like the form that was seen in total lysates 
of  monensin-treated cells; virions lacking G were not detected, 
nor was virus budding observed at the cell surface. These data 
suggest that G  protein at least facilitates the maturation Of 
VSV virions, and that virions released from monensin-treated 
cells may have formed intracellularly, perhaps at membranes 
of the Golgi complex. 
A central question is where in the cell does sorting of viral 
glycoproteins take place. Immunoelectron microscopy studies 
with ultrathin frozen sections of MDCK cells doubly infected 
with influenza virus and  VSV have been reported to show 
that HA and G proteins share a similar intracellular pathway 
of transport at least to the Golgi complex (26).  Our data are 
consistent with the idea that sorting of glycoproteins destined 
for transport to either the  apical or basolateral membrane 
domains of MDCK cells occurs within the Golgi apparatus. 
The fact that polarized maturation of viruses was maintained 
in MDCK cells doubly infected with influenza virus and VSV 
also suggested that viral membrane glycoproteins were segre- 
gated  into  different  sets  of transport  vesicles before  their 
insertion into distinct plasma membrane domains (33). There 
is  considerable  evidence that  the  Golgi  complex  plays an 
important role in the segregation of various kinds of proteins 
destined  for  different  organelles  (34).  The  possibility that 
apical  and  basolateral  glycoproteins are  inserted  over the 
entire surface of the MDCK cell, and later are sorted out to 
the "correct" membrane domain by specific retrieval mech- 
anisms, can not yet be excluded, although we have not been 
able to  detect  newly  synthesized  viral glycoproteins at the 
membrane domain other than that where budding occurs. We 
suggest that different populations of transport vesicles that 
contain different sets of viral glycoproteins are formed at the 
membranes of the Golgi, and that such vesicles are targeted 
to the apical or basolateral regions of the plasma membrane. 
Further  information on the nature  of these vesicles should 
provide direct evidence for the existence of  at least two distinct 
pathways of intracellular transport of membrane glycopro- 
teins to surfaces of polarized epithelial cells. 
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